Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Evolva Holding S.A.. (1/8/15). "Press Release: Evolva and L’Oréal Reach First Milestone in Innovative Cosmetics Ingredient Project". Reinach.

Organisations Organisation Evolva Holding SA (SIX: EVE)
  Group Evolva (Group)
  Organisation 2 L’Oréal S.A.
  Group L’Oréal (Group)
Products Product industrial biotechnology
  Product 2 cosmetics
Index term Index term L’Oréal–Evolva: biosynthetic production technology, 201402– collab developm yeast fermentation technology to produce cosmetic ingredients
Persons Person Cabirol, Fabien (L’Oréal 201501 Global Head of Biotechnologies Dept)
  Person 2 Goldsmith, Neil (Evolva –200910–201707 CEO STEPPED DOWN 7/17)
     


Evolva Holding SA (SIX: EVE) today announces the successful completion of the first part of its R&D collaboration with L’Oréal. The parties have agreed to move into the next phase of the multi-year programme.

Under this collaboration, which started in February 2014, Evolva and L’Oréal are applying Evolva’s innovative fermentation technology to develop a yeast strain optimised for sustainable and cost-effective production of a strategically important cosmetics ingredient.

With the completion of the first work package, Fabien Cabirol, L’Oreal’s new Global Head of Biotechnologies Department, said “With this partnership L’Oréal aims to leverage on Evolva strong technological platform to develop innovative cosmetic ingredients with perceivable performance and measurable sustainability benefits. L’Oréal in-house expertise combined with Evolva flexible yeast platform opens opportunities to meet the needs and aspirations of consumers”.

Evolva CEO Neil Goldsmith said. “We are pleased to have demonstrated to L’Oréal our capabilities, and the strength and elegance of our platform”.

– Ends –


About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, vanilla, saffron and resveratrol. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video.


About L’Oréal

L’Oréal has devoted itself to beauty for over 105 years. With its unique portfolio of 28 international, diverse and complementary brands, the Group generated sales amounting to 23 billion euros in 2013 and employs 77,500 people worldwide. As the world’s leading beauty company, L’Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail and branded retail. Research and innovation, and a dedicated research team of 3,600 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world and attract one billion new consumers in the years to come. L’Oréal’s new sustainability commitment for 2020 “Sharing Beauty With All” sets out ambitious sustainable development objectives across the Group’s value chain. www.loreal.com


Contact Details

Evolva
Neil Goldsmith, CEO Jakob Dynnes Hansen, CFO Paul Verbraeken, IR
neilg@evolva.com jakobdh@evolva.com paulv@evolva.com
+ 41 61 485 2005 + 41 61 485 2034 + 41 61 485 2035


This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

   
Record changed: 2017-04-02

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Evolva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top